Metabolix Inc (MBLX)

0.36
0.00 (0.00)
NASDAQ : Basic Materials
Prev Close 0.36
Open 0.36
Day Low/High 0.34 / 0.36
52 Wk Low/High 0.25 / 2.29
Volume 8.69K
Avg Volume 120.20K
Exchange NASDAQ
Shares Outstanding 28.34M
Market Cap 10.49M
EPS -0.90
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Metabolix, Inc. Announces Name Change To Yield10 Bioscience, Inc.  

Metabolix, Inc. Announces Name Change To Yield10 Bioscience, Inc.  
Metabolix Granted 180-day Extension By NASDAQ To Regain Compliance With Minimum Bid Price Rule

Metabolix Granted 180-day Extension By NASDAQ To Regain Compliance With Minimum Bid Price Rule
Metabolix Announces Third Quarter 2016 Financial Results

Metabolix Announces Third Quarter 2016 Financial Results

Metabolix To Conduct Webcast Of Its Third Quarter Conference Call

Metabolix To Conduct Webcast Of Its Third Quarter Conference Call

Metabolix To Conduct Conference Call And Live Webcast of Investor Presentation On Yield10 Bioscience

Metabolix To Conduct Conference Call And Live Webcast of Investor Presentation On Yield10 Bioscience

Metabolix Names Yield10 Bioscience Management Team; Provides Update On Strategic Restructuring And Cash Position

Metabolix Names Yield10 Bioscience Management Team; Provides Update On Strategic Restructuring And Cash Position

Dr. Kristi Snell Representing Yield10 At Policy Event Focused On Building A 21st Century Agricultural Workforce

Dr. Kristi Snell Representing Yield10 At Policy Event Focused On Building A 21st Century Agricultural Workforce

Metabolix And North Carolina State University Enter Into Worldwide, Exclusive License Agreement For Advanced Crop Technologies

Metabolix And North Carolina State University Enter Into Worldwide, Exclusive License Agreement For Advanced Crop Technologies

Metabolix Names Heike Sederoff, Ph.D. To Yield10 Bioscience Scientific Advisory Board

Metabolix Names Heike Sederoff, Ph.D. To Yield10 Bioscience Scientific Advisory Board

Metabolix Completes $10 Million Sale Of Biopolymer Assets To CJ CheilJedang

Metabolix Completes $10 Million Sale Of Biopolymer Assets To CJ CheilJedang

Metabolix Announces $10 Million Binding Letter Of Intent For Sale Of Biopolymer Assets To CJ CheilJedang

Metabolix Announces $10 Million Binding Letter Of Intent For Sale Of Biopolymer Assets To CJ CheilJedang

Metabolix Announces New Strategic Direction: Yield10 Bioscience To Become Core Business, Biopolymers Operations To Be Wound Down

Metabolix Announces New Strategic Direction: Yield10 Bioscience To Become Core Business, Biopolymers Operations To Be Wound Down

Metabolix Raises $2 Million In Amendment To Licensing Deal With Tepha

Metabolix Raises $2 Million In Amendment To Licensing Deal With Tepha

Metabolix Evaluating Strategic Alternatives For Its Specialty PHA Biopolymers Business And Yield10 Bioscience Program

Metabolix Evaluating Strategic Alternatives For Its Specialty PHA Biopolymers Business And Yield10 Bioscience Program

Metabolix To Highlight Mirel PHA Biopolymers in Packaging Applications At SustPack 2016

Metabolix To Highlight Mirel PHA Biopolymers in Packaging Applications At SustPack 2016

Metabolix Announces Fourth Quarter And Full Year 2015 Financial Results

Metabolix Announces Fourth Quarter And Full Year 2015 Financial Results

Metabolix Signs MOU With CJ CheilJedang For Strategic Commercial Manufacturing Arrangement

Metabolix Signs MOU With CJ CheilJedang For Strategic Commercial Manufacturing Arrangement

MOU Provides Path to First Tranche of Commercial Scale Capacity for Metabolix Specialty PHA Production in U.S.

Metabolix To Conduct Webcast Of Its Fourth Quarter 2015 Earnings Call

Metabolix To Conduct Webcast Of Its Fourth Quarter 2015 Earnings Call

Metabolix To Highlight Use Of Mirel PHA Biopolymers As Performance Modifiers in PLA Applications At Innovation Takes Root 2016

Metabolix To Highlight Use Of Mirel PHA Biopolymers As Performance Modifiers in PLA Applications At Innovation Takes Root 2016

Metabolix To Present At 28th Annual ROTH Conference

Metabolix To Present At 28th Annual ROTH Conference

Live Webcast on March 15, 2016 at 9:00 a.m. PT

Metabolix Announces Formation Of Scientific Advisory Board For Yield10 Bioscience

Metabolix Announces Formation Of Scientific Advisory Board For Yield10 Bioscience

Names Danny Schnell, Ph.D. and Michael Lassner, Ph.D, as Members

Metabolix To Provide Company Update At Source Capital Conference

Metabolix To Provide Company Update At Source Capital Conference

Metabolix To Present At Source Capital Conference

Metabolix To Present At Source Capital Conference

Live Webcast on February 10, 2016 at 4:00 p.m. ET

Metabolix To Relocate Corporate Headquarters To Woburn, Massachusetts In 2016

Metabolix To Relocate Corporate Headquarters To Woburn, Massachusetts In 2016

Metabolix To Present At The LD Micro Main Event

Metabolix To Present At The LD Micro Main Event

Presentation to be Webcast Live on December 2, 2015 at 3:30 p.m. PST

Metabolix Announces Third Quarter 2015 Financial Results

Metabolix Announces Third Quarter 2015 Financial Results

Metabolix To Present At Drexel Hamilton Conference

Metabolix To Present At Drexel Hamilton Conference

Presentation to be Webcast Live at 9:00 a.m. ET on November 12

Metabolix To Conduct Webcast Of Its Third Quarter 2015 Earnings Call

Metabolix To Conduct Webcast Of Its Third Quarter 2015 Earnings Call

Metabolix Signs Global, Exclusive Distribution Agreement With Kolar Filtration

Metabolix Signs Global, Exclusive Distribution Agreement With Kolar Filtration

Kolar to Market and Promote PHA-Based Denitrification Pellets for Water Treatment Applications

Metabolix, Inc. Announces $20 Million Common Stock Purchase Agreement With Aspire Capital Fund, LLC

Metabolix, Inc. Announces $20 Million Common Stock Purchase Agreement With Aspire Capital Fund, LLC

Load More

From Our Partners

Metabolix set for change to Yield10 Bioscience
SeekingAlpha

Metabolix, Inc. 2016 Q3 - Results - Earnings Call Slides
SeekingAlpha

Metabolix reports Q3 results
SeekingAlpha

Metabolix to sell biopolymer assets to Korean group for $10M
SeekingAlpha

Metabolix initiated with a Buy at Rodman & Renshaw
The Fly

After-Hours Earnings Report for March 26, 2013 : SAI, MFRM, LNDC, MBLX, BONE, SNWV
NASDAQ

Morning Market Movers
Benzinga

Company News for January 16, 2012 - Corporate Summary
Zacks

UPDATE: ADM to End Commercial Alliance with Metabolix
Benzinga

UPDATE 1-Metabolix grasping for profits in renewable plastics
Reuters

Metabolix to Present at Jefferies & Company's 10th Annual Global Clean Technologies Conference
Benzinga

Piper Jaffray Neutral On Shares Of Metabolix, Lifts Pirce Target (MBLX)
Benzinga

Zacks Analyst Blog Highlights: Goodyear Tire, Metabolix, Spartech, Perry Ellis and Phillips Van Heusen - Press Releases
Zacks

ISM Reaches 6-Year High - Analyst Blog
Zacks

Trending
We Went to Sears For The First Time In More Than 10 Years and Instantly Saw Why It's Dying
24 Large Retailers Besides J.C. Penney Are Closing Waves of Stores
15 Great Dividend Stocks to Own Should the Surging Stock Market Plunge This Summer
FTC Seen as Set to Block Rite Aid Deal
We Just Drove a Brand New BMW That Basically Turns Into a Cool Nightclub in the Evening